BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

294 related articles for article (PubMed ID: 36381379)

  • 1. Left ventricular dysfunction with preserved ejection fraction: the most common left ventricular disorder in chronic kidney disease patients.
    Mark PB; Mangion K; Rankin AJ; Rutherford E; Lang NN; Petrie MC; Stoumpos S; Patel RK
    Clin Kidney J; 2022 Dec; 15(12):2186-2199. PubMed ID: 36381379
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interrelation between heart failure with preserved ejection fraction and renal impairment.
    Joslin JR; Lioudaki E; Androulakis E
    Rev Cardiovasc Med; 2022 Feb; 23(2):69. PubMed ID: 35229560
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Telmisartan ameliorates cardiac fibrosis and diastolic function in cardiorenal heart failure with preserved ejection fraction.
    Chang D; Xu TT; Zhang SJ; Cai Y; Min SD; Zhao Z; Lu CQ; Wang YC; Ju S
    Exp Biol Med (Maywood); 2021 Dec; 246(23):2511-2521. PubMed ID: 34342551
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epidemiology and Management of Patients With Kidney Disease and Heart Failure With Preserved Ejection Fraction.
    Tuttle ML; Fang JC; Sarnak MJ; McCallum W
    Semin Nephrol; 2024 May; ():151516. PubMed ID: 38704338
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heart Failure With Preserved Ejection Fraction With CKD: A Narrative Review of a Multispecialty Disorder.
    Patel RN; Sharma A; Prasad A; Bansal S
    Kidney Med; 2023 Dec; 5(12):100705. PubMed ID: 38046909
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chronic Kidney Disease as a Risk Factor for Heart Failure With Preserved Ejection Fraction: A Focus on Microcirculatory Factors and Therapeutic Targets.
    van de Wouw J; Broekhuizen M; Sorop O; Joles JA; Verhaar MC; Duncker DJ; Danser AHJ; Merkus D
    Front Physiol; 2019; 10():1108. PubMed ID: 31551803
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlation Between Liver Stiffness and Diastolic Function, Left Ventricular Hypertrophy, and Right Cardiac Function in Patients With Ejection Fraction Preserved Heart Failure.
    Zhang J; Xu M; Chen T; Zhou Y
    Front Cardiovasc Med; 2021; 8():748173. PubMed ID: 34901210
    [No Abstract]   [Full Text] [Related]  

  • 8. Association of Chronic Kidney Disease with Preserved Ejection Fraction Heart Failure Is Independent of Baseline Cardiac Function.
    Mavrakanas TA; Khattak A; Wang W; Singh K; Charytan DM
    Kidney Blood Press Res; 2019; 44(5):1247-1258. PubMed ID: 31476759
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anemia has an impact on prognosis in heart failure with preserved ejection fraction with mild chronic kidney disease.
    Okuno K; Naito Y; Asakura M; Sugahara M; Horimatsu T; Yasumura S; Tahara S; Nagai T; Saito Y; Yoshikawa T; Masuyama T; Ishihara M; Anzai T
    Int J Cardiol Heart Vasc; 2021 Jun; 34():100796. PubMed ID: 34095449
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of Renin-angiotensin-aldosterone-system inhibitors for heart failure with preserved ejection fraction and left ventricular hypertrophy -from the KUNIUMI Registry Acute Cohort.
    Odajima S; Tanaka H; Fujimoto W; Kuroda K; Yamashita S; Imanishi J; Iwasaki M; Todoroki T; Okuda M; Hayashi T; Konishi A; Shinohara M; Toh R; Hirata KI
    J Cardiol; 2022 Jun; 79(6):703-710. PubMed ID: 34924235
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impaired systolic function by strain imaging in heart failure with preserved ejection fraction.
    Kraigher-Krainer E; Shah AM; Gupta DK; Santos A; Claggett B; Pieske B; Zile MR; Voors AA; Lefkowitz MP; Packer M; McMurray JJ; Solomon SD;
    J Am Coll Cardiol; 2014 Feb; 63(5):447-56. PubMed ID: 24184245
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Echocardiographic Features of Patients With Heart Failure and Preserved Left Ventricular Ejection Fraction.
    Shah AM; Cikes M; Prasad N; Li G; Getchevski S; Claggett B; Rizkala A; Lukashevich I; O'Meara E; Ryan JJ; Shah SJ; Mullens W; Zile MR; Lam CSP; McMurray JJV; Solomon SD;
    J Am Coll Cardiol; 2019 Dec; 74(23):2858-2873. PubMed ID: 31806129
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 2024 Guidelines of the Taiwan Society of Cardiology for the Diagnosis and Treatment of Heart Failure with Preserved Ejection Fraction.
    Li YH; Wang CC; Hung CL; Wu YW; Hsu CH; Tsou YL; Wang CH; Wu CK; Lin PL; Chang HY; Sung SH; Chen ZW; Juang JJ; Wang TD; Chen WJ
    Acta Cardiol Sin; 2024 Mar; 40(2):148-171. PubMed ID: 38532817
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Allogeneic Cell Combination Therapy Ameliorates Chronic Kidney Disease-Induced Heart Failure with Preserved Ejection Fraction.
    Rieger AC; Tompkins BA; Natsumeda M; Florea V; Banerjee MN; Rodriguez J; Rosado M; Porras V; Valasaki K; Takeuchi LM; Collon K; Desai S; Bellio MA; Khan A; Kashikar ND; Landin AM; Hardin DV; Rodriguez DA; Balkan W; Hare JM; Schulman IH
    Stem Cells Transl Med; 2022 Mar; 11(1):59-72. PubMed ID: 35641169
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevention of heart failure with preserved ejection fraction (HFpEF): reexamining microRNA-21 inhibition in the era of oligonucleotide-based therapeutics.
    Ben-Nun D; Buja LM; Fuentes F
    Cardiovasc Pathol; 2020; 49():107243. PubMed ID: 32629211
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dual Endothelin-A/Endothelin-B Receptor Blockade and Cardiac Remodeling in Heart Failure With Preserved Ejection Fraction.
    Valero-Munoz M; Li S; Wilson RM; Boldbaatar B; Iglarz M; Sam F
    Circ Heart Fail; 2016 Nov; 9(11):. PubMed ID: 27810862
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of chronic kidney disease with abnormal cardiac mechanics and adverse outcomes in patients with heart failure and preserved ejection fraction.
    Unger ED; Dubin RF; Deo R; Daruwalla V; Friedman JL; Medina C; Beussink L; Freed BH; Shah SJ
    Eur J Heart Fail; 2016 Jan; 18(1):103-12. PubMed ID: 26635076
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Therapy and Management of Heart Failure with Preserved Ejection Fraction: New Insights on Treatment.
    Balestrieri G; Limonta R; Ponti E; Merlo A; Sciatti E; D'Isa S; Gori M; Casu G; Giannattasio C; Senni M; D'Elia E
    Card Fail Rev; 2024; 10():e05. PubMed ID: 38708376
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel mouse model of heart failure with preserved ejection fraction after chronic kidney disease induced by retinol through JAK/STAT pathway.
    Liu B; Shalamu A; Pei Z; Liu L; Wei Z; Qu Y; Song S; Luo W; Dong Z; Weng X; Ge J
    Int J Biol Sci; 2023; 19(12):3661-3677. PubMed ID: 37564202
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Left ventricular diastolic pressure gradient and outcome in advanced chronic kidney disease patients with preserved ejection fraction.
    Zhong Y; Cai Y; Liu M; Bai W; Wang F; Tang H; Rao L
    Int J Cardiovasc Imaging; 2021 Sep; 37(9):2663-2673. PubMed ID: 34286450
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.